Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors
Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors
Active, not recruiting · NCT07021066 · Registry updated 2026-08-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors | Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, biliary tract cancer, biliary tract disorder, esophageal adenocarcinoma, gastric adenocarcinoma, neoplasm | Active, not recruiting | Phase 1 | 2026-08-05 | NCT07021066 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| SystImmune Inc. | 24 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hackensack University Medical Center | Hackensack | United States | 308 |
| HonorHealth | Scottsdale | United States | 1 |
| Next Oncology San Antonio | San Antonio | United States | 6 |
| NEXT Oncology- Austin | Austin | United States | 1 |
| NEXT Oncology- Dallas | Dallas | United States | 1 |
| Ochsner Medical Center | New Orleans | United States | 26 |
| Sarah Cannon Research Institute - Oncology Partners | Nashville | United States | 4 |
| University of Colorado Health | Aurora | United States | 6 |
| University of Michigan | Ann Arbor | United States | 538 |
| Valkyrie Clinical Trials | Los Angeles | United States | 47 |
| Yale Cancer Center | New Haven | United States | 42 |